BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a large decrease in short interest in December. As of December 31st, there was short interest totalling 48,200 shares, a decrease of 61.2% from the December 15th total of 124,200 shares. Based on an average daily trading volume, of 365,000 shares, the short-interest ratio is presently 0.1 days.

BlackRock Health Sciences Term Trust Stock Performance

NYSE:BMEZ opened at $15.25 on Thursday. BlackRock Health Sciences Term Trust has a 12 month low of $14.27 and a 12 month high of $16.59. The firm has a fifty day simple moving average of $15.29 and a two-hundred day simple moving average of $15.58.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Friday, January 31st. Investors of record on Wednesday, January 15th will be given a $0.1782 dividend. This represents a $2.14 dividend on an annualized basis and a yield of 14.02%. The ex-dividend date is Wednesday, January 15th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Brown Brothers Harriman & Co. bought a new position in shares of BlackRock Health Sciences Term Trust in the 3rd quarter worth $32,000. K2 Principal Fund L.P. acquired a new position in BlackRock Health Sciences Term Trust during the third quarter worth $158,000. Dakota Wealth Management raised its holdings in BlackRock Health Sciences Term Trust by 23.4% during the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock worth $357,000 after buying an additional 4,267 shares during the last quarter. Jane Street Group LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the third quarter valued at $357,000. Finally, Brown Lisle Cummings Inc. grew its holdings in shares of BlackRock Health Sciences Term Trust by 6.2% during the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock valued at $578,000 after buying an additional 2,128 shares during the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.